TP53 and breast carcinoma: Germline mutations in TP53 predispose people to Li–Fraumeni syndrome (LFS), which is characterized by early onset of cancers, including breast cancer, sarcomas, brain tumors, leukemia, and adrenocortical carcinomas [8,9,10].